The vast majority of Medicare beneficiaries with infection of a cardiac implanted electronic device (CIED) don’t have their hardware removed within 30 days, contrary to guideline recommendations, and ...

Less than one out of every eight patients with infective endocarditis and a cardiac implantable electronic device (CIED) underwent recommended transvenous lead removal/extraction over a recent 4-year ...

Please provide your email address to receive an email when new articles are posted on . Xcardia Innovation Ltd., following the February FDA 510(k) clearance of its device for cardiac pacemaker and ...

Infections associated with pacemaker or implantable defibrillator systems, even when limited to the subcutaneous pocket, generally call for removal of the pulse-generator and leads. But alternative ...

ORLANDO, Florida — Transvenous extraction of unused pacemaker or defibrillator leads poses a higher risk for death as an acute complication when it's performed by using a laser-based extraction sheath ...

Cardiac implantable electronic devices (CIEDs), including pacemakers, defibrillators and cardiac resynchronisation systems, have transformed the treatment of arrhythmias and heart failure. However, ...

When extracts of a medical device are required for a biocompatibility test protocol, a current practice is to follow the guidance in ISO 10993 Biological evaluation of medical devices–Part 12: Sample ...